<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36980948</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4425</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>08</Day></PubDate></JournalIssue><Title>Genes</Title><ISOAbbreviation>Genes (Basel)</ISOAbbreviation></Journal><ArticleTitle>Novel Variants in the <i>VCP</i> Gene Causing Multisystem Proteinopathy 1.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">676</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/genes14030676</ELocationID><Abstract><AbstractText>Valosin-containing protein (<i>VCP</i>) gene mutations have been associated with a rare autosomal dominant, adult-onset progressive disease known as multisystem proteinopathy 1 (MSP1), or inclusion body myopathy (IBM), Paget's disease of bone (PDB), frontotemporal dementia (FTD), (IBMPFD), and amyotrophic lateral sclerosis (ALS). We report the clinical and genetic analysis findings in five patients, three from the same family, with novel <i>VCP</i> gene variants: NM_007126.5 <i>c.1106T&gt;C</i> (<i>p.I369T</i>), <i>c.478G&gt;A</i> (<i>p.A160T</i>), and <i>c.760A&gt;T</i> (<i>p.I254F</i>), associated with cardinal MSP1 manifestations including myopathy, PDB, and FTD. Our report adds to the spectrum of heterozygous pathogenic variants found in the <i>VCP</i> gene and the high degree of clinical heterogeneity. This case series prompts increased awareness and early consideration of MSP1 in the differential diagnosis of myopathies and/or PDB, dementia, or ALS to improve the diagnosis and early management of clinical symptoms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Columbres</LastName><ForeName>Rod Carlo Agram</ForeName><Initials>RCA</Initials><Identifier Source="ORCID">0000-0002-4134-6054</Identifier><AffiliationInfo><Affiliation>Division of Genetics and Genomic Medicine, Department of Pediatrics, University of California, Irvine, CA 92697, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Osteopathic Medicine, William Carey University, Hattiesburg, MS 39401, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chin</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Osteopathic Medicine, William Carey University, Hattiesburg, MS 39401, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pratti</LastName><ForeName>Sanjana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>College of Osteopathic Medicine, William Carey University, Hattiesburg, MS 39401, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quinn</LastName><ForeName>Colin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez-Cuyar</LastName><ForeName>Luis F</ForeName><Initials>LF</Initials><Identifier Source="ORCID">0000-0002-8424-8331</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiss</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4064-1032</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quintero-Rivera</LastName><ForeName>Fabiola</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Genetics and Genomic Medicine, Department of Pediatrics, University of California, Irvine, CA 92697, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of California, Irvine, CA 92697, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kimonis</LastName><ForeName>Virginia</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-1567-4449</Identifier><AffiliationInfo><Affiliation>Division of Genetics and Genomic Medicine, Department of Pediatrics, University of California, Irvine, CA 92697, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of California, Irvine, CA 92697, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, University of California, Irvine, CA 92697, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Genes (Basel)</MedlineTA><NlmUniqueID>101551097</NlmUniqueID><ISSNLinking>2073-4425</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.6.4.6</RegistryNumber><NameOfSubstance UI="D000074405">Valosin Containing Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018797">Cell Cycle Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020066">Merozoite Surface Protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.6</RegistryNumber><NameOfSubstance UI="C000614178">VCP protein, human</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C563476">Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010001" MajorTopicYN="Y">Osteitis Deformans</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000074405" MajorTopicYN="N">Valosin Containing Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018797" MajorTopicYN="N">Cell Cycle Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020066" MajorTopicYN="N">Merozoite Surface Protein 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018979" MajorTopicYN="Y">Myositis, Inclusion Body</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">IBMPFD</Keyword><Keyword MajorTopicYN="N">MSP1</Keyword><Keyword MajorTopicYN="N">VCP</Keyword><Keyword MajorTopicYN="N">multisystem proteinopathy-1</Keyword><Keyword MajorTopicYN="N">valosin-containing protein</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>1</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36980948</ArticleId><ArticleId IdType="pmc">PMC10048343</ArticleId><ArticleId IdType="doi">10.3390/genes14030676</ArticleId><ArticleId IdType="pii">genes14030676</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kimonis V.E., Kovach M.J., Waggoner B., Leal S., Salam A., Rimer L., Davis K., Khardori R., Gelber D. Clinical and molecular studies in a unique family with autosomal dominant limb-girdle muscular dystrophy and Paget disease of bone. Genet. Med. 2000;2:232&#x2013;241. doi: 10.1097/00125817-200007000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00125817-200007000-00006</ArticleId><ArticleId IdType="pmc">PMC6173187</ArticleId><ArticleId IdType="pubmed">11252708</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimonis V.E., Mehta S.G., Fulchiero E.C., Thomasova D., Pasquali M., Boycott K., Neilan E.G., Kartashov A., Forman M.S., Tucker S., et al. Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia. Am. J. Med. Genet. Part A. 2008;146:745&#x2013;757. doi: 10.1002/ajmg.a.31862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.a.31862</ArticleId><ArticleId IdType="pmc">PMC2467391</ArticleId><ArticleId IdType="pubmed">18260132</ArticleId></ArticleIdList></Reference><Reference><Citation>Korb M., Peck A., Alfano L.N., Berger K.I., James M.K., Ghoshal N., Healzer E., Henchcliffe C., Khan S., Mammen P.P.A., et al. Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy. Orphanet J. Rare Dis. 2022;17:23. doi: 10.1186/s13023-022-02172-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-022-02172-5</ArticleId><ArticleId IdType="pmc">PMC8800193</ArticleId><ArticleId IdType="pubmed">35093159</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiava M., Ikenaga C., Villar-Quiles R.N., Caballero-&#xc1;vila M., Topf A., Nishino I., Kimonis V., Udd B., Schoser B., Zanoteli E., et al. Genotype-phenotype correlations in valosin-containing protein disease: A retrospective muticentre study. J. Neurol. Neurosurg. Psychiatry. 2022;93:1099&#x2013;1111. doi: 10.1136/jnnp-2022-328921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2022-328921</ArticleId><ArticleId IdType="pmc">PMC9880250</ArticleId><ArticleId IdType="pubmed">35896379</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Obeidi E., Al-Tahan S., Surampalli A., Goyal N., Wang A., Hermann A., Omizo M., Smith C., Mozaffar T., Kimonis V. Genotype-phenotype study in patients with valosin-containing protein mutations associated with multisystem proteinopathy. Clin. Genet. 2018;93:119&#x2013;125. doi: 10.1111/cge.13095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cge.13095</ArticleId><ArticleId IdType="pmc">PMC5739971</ArticleId><ArticleId IdType="pubmed">28692196</ArticleId></ArticleIdList></Reference><Reference><Citation>Farpour F., Tehranzadeh J., Donkervoort S., Smith C., Martin B., Vanjara P., Osann K., Kimonis V.E. Radiological features of Paget disease of bone associated with VCP myopathy. Skelet. Radiol. 2012;41:329&#x2013;337. doi: 10.1007/s00256-011-1193-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00256-011-1193-4</ArticleId><ArticleId IdType="pubmed">21643886</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Donkervoort S., Dec E., Badadani M., Katheria V., Rana P., Nguyen C., Mukherjee J., Caiozzo V., Martin B., et al. The Multiple Faces of Valosin-Containing Protein-Associated Diseases: Inclusion Body Myopathy with Paget&#x2019;s Disease of Bone, Frontotemporal Dementia, and Amyotrophic Lateral Sclerosis. J. Mol. Neurosci. 2011;45:522&#x2013;531. doi: 10.1007/s12031-011-9627-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-011-9627-y</ArticleId><ArticleId IdType="pubmed">21892620</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta S., Khare M., Ramani R., Watts G., Simon M., Osann K., Donkervoort S., Dec E., Nalbandian A., Platt J., et al. Genotype&#x2013;phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia. Clin. Genet. 2013;83:422&#x2013;431. doi: 10.1111/cge.12000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cge.12000</ArticleId><ArticleId IdType="pmc">PMC3618576</ArticleId><ArticleId IdType="pubmed">22909335</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss L., Jung K.-M., Nalbandian A., Llewellyn K., Yu H., Ta L., Chang I., Migliore M., Squire E., Ahmed F., et al. Ceramide contributes to pathogenesis and may be targeted for therapy in VCP inclusion body myopathy. Hum. Mol. Genet. 2021;29:3945&#x2013;3953. doi: 10.1093/hmg/ddaa248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddaa248</ArticleId><ArticleId IdType="pmc">PMC8485215</ArticleId><ArticleId IdType="pubmed">33410456</ArticleId></ArticleIdList></Reference><Reference><Citation>Dardis C., Antezana A., Tanji K., Maccabee P.J. Inclusion Body Myositis: A Case Presenting with Respiratory Failure and Autopsy Findings Leading to the Hypothesis of a Paraneoplastic Cause. Am. J. Case Rep. 2017;18:700&#x2013;706. doi: 10.12659/AJCR.903566.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/AJCR.903566</ArticleId><ArticleId IdType="pmc">PMC5490508</ArticleId><ArticleId IdType="pubmed">28642454</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimachkie M.M., Barohn R.J. Inclusion body myositis. Neurol. Clin. 2014;32:629&#x2013;646. doi: 10.1016/j.ncl.2014.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2014.04.001</ArticleId><ArticleId IdType="pmc">PMC4115580</ArticleId><ArticleId IdType="pubmed">25037082</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.C., Smith C.D., Lombardo D.M., Kimonis V. Characteristics of VCP mutation-associated cardiomyopathy. Neuromuscul. Disord. 2021;31:701&#x2013;705. doi: 10.1016/j.nmd.2021.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2021.06.005</ArticleId><ArticleId IdType="pubmed">34244020</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikenaga C., Findlay A.R., Seiffert M., Peck A., Peck N., Johnson N.E., Statland J.M., Weihl C.C. Phenotypic diversity in an international Cure VCP Disease registry. Orphanet J. Rare Dis. 2020;15:267. doi: 10.1186/s13023-020-01551-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-020-01551-0</ArticleId><ArticleId IdType="pmc">PMC7523394</ArticleId><ArticleId IdType="pubmed">32993728</ArticleId></ArticleIdList></Reference><Reference><Citation>Naddaf E., Barohn R.J., Dimachkie M.M. Inclusion Body Myositis: Update on Pathogenesis and Treatment. Neurotherapeutics. 2018;15:995&#x2013;1005. doi: 10.1007/s13311-018-0658-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-018-0658-8</ArticleId><ArticleId IdType="pmc">PMC6277289</ArticleId><ArticleId IdType="pubmed">30136253</ArticleId></ArticleIdList></Reference><Reference><Citation>Bola&#xf1;os-Toro F., Arias-Jaramillo D., Aun-Mej&#xed;a M., Castro-Henao J., Fern&#xe1;ndez-&#xc1;vila D.G., Saldarriaga-Rivera L.M. Inclusion body myositis: A differential diagnosis to consider in patients with myopathy refractory to immunosuppressants. Two case reports. Rev. Colomb. Reumatol. Engl. Ed. 2021;28:300&#x2013;305. doi: 10.1016/j.rcreue.2020.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rcreue.2020.05.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaker J.L. Paget&#x2019;s Disease of Bone: A Review of Epidemiology, Pathophysiology and Management. Ther. Adv. Musculoskelet. Dis. 2009;1:107&#x2013;125. doi: 10.1177/1759720X09351779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1759720X09351779</ArticleId><ArticleId IdType="pmc">PMC3383486</ArticleId><ArticleId IdType="pubmed">22870432</ArticleId></ArticleIdList></Reference><Reference><Citation>Ralston S.H., Corral-Gudino L., Cooper C., Francis R.M., Fraser W.D., Gennari L., Gua&#xf1;abens N., Javaid M.K., Layfield R., O&#x2019;Neill T.W., et al. Diagnosis and Management of Paget&#x2019;s Disease of Bone in Adults: A Clinical Guideline. J. Bone Miner. Res. 2019;34:579&#x2013;604. doi: 10.1002/jbmr.3873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.3873</ArticleId><ArticleId IdType="pmc">PMC6522384</ArticleId><ArticleId IdType="pubmed">30803025</ArticleId></ArticleIdList></Reference><Reference><Citation>Paget&#x2019;s Disease&#x2014;Pathology&#x2014;Orthobullets.  [(accessed on 11 November 2022)].  Available online:  https://www.orthobullets.com/pathology/8040/pagets-disease.</Citation></Reference><Reference><Citation>Griepp D.W., Sajan A., Sighary M. Diffuse Paget&#x2019;s Disease of the Skull with Intense Uptake of Technetium-99m-Labeled Diphosphonate Tracer in Bone Scintigraphy. World Neurosurg. 2021;151:89&#x2013;90. doi: 10.1016/j.wneu.2021.04.101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2021.04.101</ArticleId><ArticleId IdType="pubmed">33940269</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen H.J., Allison S.C., Schauer G.F., Gorno-Tempini M.L., Weiner M.W., Miller B.L. Neuroanatomical correlates of behavioural disorders in dementia. Brain J. Neurol. 2005;128:2612&#x2013;2625. doi: 10.1093/brain/awh628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh628</ArticleId><ArticleId IdType="pmc">PMC1820861</ArticleId><ArticleId IdType="pubmed">16195246</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman D.S., Boeve B.F., Parisi J.E., Dickson D.W., Smith G.E., Ivnik R.J., Josephs K.A., Petersen R.C. Antemortem diagnosis of frontotemporal lobar degeneration. Ann. Neurol. 2005;57:480&#x2013;488. doi: 10.1002/ana.20425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20425</ArticleId><ArticleId IdType="pubmed">15786453</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner J.M., Al-Chalabi A., Baker M.R., Cui L.-Y., de Carvalho M., Eisen A., Grosskreutz J., Hardiman O., Henderson R., Matamala J.M., et al. A proposal for new diagnostic criteria for ALS. Clin. Neurophysiol. 2020;131:1975&#x2013;1978. doi: 10.1016/j.clinph.2020.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.04.005</ArticleId><ArticleId IdType="pubmed">32387049</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer H., Weihl C.C. The VCP/p97 system at a glance: Connecting cellular function to disease pathogenesis. J. Cell Sci. 2014;127:3877&#x2013;3883. doi: 10.1242/jcs.093831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.093831</ArticleId><ArticleId IdType="pmc">PMC4163641</ArticleId><ArticleId IdType="pubmed">25146396</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinovich E., Kerem A., Fr&#xf6;hlich K.U., Diamant N., Bar-Nun S. AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol. Cell. Biol. 2002;22:626&#x2013;634. doi: 10.1128/MCB.22.2.626-634.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.22.2.626-634.2002</ArticleId><ArticleId IdType="pmc">PMC139744</ArticleId><ArticleId IdType="pubmed">11756557</ArticleId></ArticleIdList></Reference><Reference><Citation>Rape M., Hoppe T., Gorr I., Kalocay M., Richly H., Jentsch S. Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone. Cell. 2001;107:667&#x2013;677. doi: 10.1016/S0092-8674(01)00595-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(01)00595-5</ArticleId><ArticleId IdType="pubmed">11733065</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih Y.T., Hsueh Y.P. VCP and ATL1 regulate endoplasmic reticulum and protein synthesis for dendritic spine formation. Nat. Commun. 2016;7:11020. doi: 10.1038/ncomms11020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11020</ArticleId><ArticleId IdType="pmc">PMC4800434</ArticleId><ArticleId IdType="pubmed">26984393</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju J.-S., Fuentealba R., Miller S.E., Jackson E., Piwnica-Worms D., Baloh R.H., Weihl C.C. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J. Cell Biol. 2009;187:875&#x2013;888. doi: 10.1083/jcb.200908115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908115</ArticleId><ArticleId IdType="pmc">PMC2806317</ArticleId><ArticleId IdType="pubmed">20008565</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts G.D.J., Wymer J., Kovach M.J., Mehta S.G., Mumm S., Darvish D., Pestronk A., Whyte M.P., E Kimonis V. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 2004;36:377&#x2013;381. doi: 10.1038/ng1332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1332</ArticleId><ArticleId IdType="pubmed">15034582</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalal S., Rosser M.F.N., Cyr D.M., Hanson P.I. Distinct roles for the AAA ATPases NSF and p97 in the secretory pathway. Mol. Biol. Cell. 2004;15:637&#x2013;648. doi: 10.1091/mbc.e03-02-0097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e03-02-0097</ArticleId><ArticleId IdType="pmc">PMC329284</ArticleId><ArticleId IdType="pubmed">14617820</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia D., Tang W.K., Ye Y. Structure and function of the AAA+ ATPase p97/Cdc48p. Gene. 2016;583:64&#x2013;77. doi: 10.1016/j.gene.2016.02.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2016.02.042</ArticleId><ArticleId IdType="pmc">PMC4821690</ArticleId><ArticleId IdType="pubmed">26945625</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchberger A., Schindelin H., H&#xe4;nzelmann P. Control of p97 function by cofactor binding. FEBS Lett. 2015;589:2578&#x2013;2589. doi: 10.1016/j.febslet.2015.08.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2015.08.028</ArticleId><ArticleId IdType="pubmed">26320413</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung H.O., Kloppsteck P., Niwa H., Isaacson R.L., Matthews S., Zhang X., Freemont P.S. Insights into adaptor binding to the AAA protein p97. Biochem. Soc. Trans. 2008;36:62&#x2013;67. doi: 10.1042/BST0360062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST0360062</ArticleId><ArticleId IdType="pubmed">18208387</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman E., Maksim N., de la Cruz F., La Clair J.J. Inhibitors of the AAA+ chaperone p97. Molecules. 2015;20:3027&#x2013;3049. doi: 10.3390/molecules20023027.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules20023027</ArticleId><ArticleId IdType="pmc">PMC4576884</ArticleId><ArticleId IdType="pubmed">25685910</ArticleId></ArticleIdList></Reference><Reference><Citation>Niwa H., Ewens C.A., Tsang C., Yeung H.O., Zhang X., Freemont P.S. The role of the N-domain in the ATPase activity of the mammalian AAA ATPase p97/VCP. J. Biol. Chem. 2012;287:8561&#x2013;8570. doi: 10.1074/jbc.M111.302778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.302778</ArticleId><ArticleId IdType="pmc">PMC3318706</ArticleId><ArticleId IdType="pubmed">22270372</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang W.K., Xia D. Altered intersubunit communication is the molecular basis for functional defects of pathogenic p97 mutants. J. Biol. Chem. 2013;288:36624&#x2013;36635. doi: 10.1074/jbc.M113.488924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.488924</ArticleId><ArticleId IdType="pmc">PMC3868774</ArticleId><ArticleId IdType="pubmed">24196964</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreveny I., Kondo H., Uchiyama K., Shaw A., Zhang X., Freemont P.S. Structural basis of the interaction between the AAA ATPase p97/VCP and its adaptor protein p47. EMBO J. 2004;23:1030&#x2013;1039. doi: 10.1038/sj.emboj.7600139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7600139</ArticleId><ArticleId IdType="pmc">PMC380986</ArticleId><ArticleId IdType="pubmed">14988733</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;nzelmann P., Buchberger A., Schindelin H. Hierarchical binding of cofactors to the AAA ATPase p97. Structure. 2011;19:833&#x2013;843. doi: 10.1016/j.str.2011.03.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2011.03.018</ArticleId><ArticleId IdType="pubmed">21645854</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang W.K., Li D., Li C.-C., Esser L., Dai R., Guo L., Xia D. A novel ATP-dependent conformation in p97 N-D1 fragment revealed by crystal structures of disease-related mutants. EMBO J. 2010;29:2217&#x2013;2229. doi: 10.1038/emboj.2010.104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.104</ArticleId><ArticleId IdType="pmc">PMC2905243</ArticleId><ArticleId IdType="pubmed">20512113</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Shaw A., Bates P.A., Newman R.H., Gowen B., Orlova E., Gorman M.A., Kondo H., Dokurno P., Lally J., et al. Structure of the AAA ATPase p97. Mol. Cell. 2000;6:1473&#x2013;1484. doi: 10.1016/S1097-2765(00)00143-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(00)00143-X</ArticleId><ArticleId IdType="pubmed">11163219</ArticleId></ArticleIdList></Reference><Reference><Citation>Saracino D., Clot F., Camuzat A., Anquetil V., Hannequin D., Guyant-Mar&#xe9;chal L., Didic M., Guillot-No&#xeb;l L., Rinaldi D., Latouche M., et al. Novel VCP mutations expand the mutational spectrum of frontotemporal dementia. Neurobiol. Aging. 2018;72:187.e11&#x2013;187.e14. doi: 10.1016/j.neurobiolaging.2018.06.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.06.037</ArticleId><ArticleId IdType="pubmed">30005904</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandi P., Li S., Columbres R.C.A., Wang F., Williams D., Poh Y.-P., Chou T.-F., Chiu P.-L. Structural and Functional Analysis of Disease-Linked p97 ATPase Mutant Complexes. Int J. Mol. Sci. 2021;22:8079. doi: 10.3390/ijms22158079.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22158079</ArticleId><ArticleId IdType="pmc">PMC8347982</ArticleId><ArticleId IdType="pubmed">34360842</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeffer G., Lee G., Pontifex C.S., Fanganiello R.D., Peck A., Weihl C.C., Kimonis V. Multisystem Proteinopathy Due to VCP Mutations: A Review of Clinical Heterogeneity and Genetic Diagnosis. Genes. 2022;13:963. doi: 10.3390/genes13060963.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes13060963</ArticleId><ArticleId IdType="pmc">PMC9222868</ArticleId><ArticleId IdType="pubmed">35741724</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Tahan S., Al-Obeidi E., Yoshioka H., Lakatos A., Weiss L., Grafe M., Palmio J., Wicklund M., Harati Y., Omizo M., et al. Novel valosin-containing protein mutations associated with multisystem proteinopathy. Neuromuscul. Disord. 2018;28:491&#x2013;501. doi: 10.1016/j.nmd.2018.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2018.04.007</ArticleId><ArticleId IdType="pubmed">29754758</ArticleId></ArticleIdList></Reference><Reference><Citation>Surampalli A. A Clinicopathologic Case Report of a Female with Valosin-Containing Protein (VCP) Gene Mutation Related Disease. Int. J. Neurodegener. Dis. 2018;1:6. doi: 10.23937/IJND-2017/1710006.</Citation><ArticleIdList><ArticleId IdType="doi">10.23937/IJND-2017/1710006</ArticleId></ArticleIdList></Reference><Reference><Citation>De Ridder W., Azmi A., Clemen C.S., Eichinger L., Hofmann A., Schr&#xf6;der R., Johnson K., T&#xf6;pf A., Straub V., De Jonghe P., et al. Multisystem proteinopathy due to a homozygous p.Arg159His VCP mutation: A tale of the unexpected. Neurology. 2020;94:e785&#x2013;e796. doi: 10.1212/WNL.0000000000008763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008763</ArticleId><ArticleId IdType="pubmed">31848255</ArticleId></ArticleIdList></Reference><Reference><Citation>Jerath N.U. Resolving a Multi-Generational Neuromuscular Mystery in a Family Presenting with a Variable Scapuloperoneal Syndrome in a c.464G&gt;A, p.Arg155His VCP Mutation. Case Rep. Genet. 2019;2019:2403024. doi: 10.1155/2019/2403024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/2403024</ArticleId><ArticleId IdType="pmc">PMC6803746</ArticleId><ArticleId IdType="pubmed">31687228</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng S.Y., Lin H., Che C.H., Huang H.P., Liu C.Y., Zou Z.Y. Phenotype of VCP Mutations in Chinese Amyotrophic Lateral Sclerosis Patients. Front. Neurol. 2022;13:790082. doi: 10.3389/fneur.2022.790082.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.790082</ArticleId><ArticleId IdType="pmc">PMC8858817</ArticleId><ArticleId IdType="pubmed">35197922</ArticleId></ArticleIdList></Reference><Reference><Citation>Choy N., Wang S., Abbona P., Leffler D., Kimonis V. Severe cardiomyopathy associated with the VCP p.R155C and c.177_187del MYBPC3 gene variants. Eur. J. Med. Genet. 2022;65:104480. doi: 10.1016/j.ejmg.2022.104480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmg.2022.104480</ArticleId><ArticleId IdType="pubmed">35306227</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsubara T., Izumi Y., Oda M., Takahashi M., Maruyama H., Miyamoto R., Watanabe C., Tachiyama Y., Morino H., Kawakami H., et al. An autopsy report of a familial amyotrophic lateral sclerosis case carrying VCP Arg487His mutation with a unique TDP-43 proteinopathy. Neuropathology. 2021;41:118&#x2013;126. doi: 10.1111/neup.12710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12710</ArticleId><ArticleId IdType="pubmed">33415820</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellerin D., Ellezam B., Korathanakhun P., Renaud M., Dicaire M.-J., Pilote L., Levy J.P., Karamchandani J., Ducharme S., Massie R., et al. Multisystem Proteinopathy Associated with a VCP G156S Mutation in a French Canadian Family. Can. J. Neurol. Sci. 2020;47:412&#x2013;415. doi: 10.1017/cjn.2020.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2020.25</ArticleId><ArticleId IdType="pubmed">32036797</ArticleId></ArticleIdList></Reference><Reference><Citation>Falc&#xe3;o de Campos C., de Carvalho M. Distal myopathy and rapidly progressive dementia associated with a novel mutation in the VCP gene: Expanding inclusion body myopathy with early-onset Paget disease and frontotemporal dementia spectrum. J. Clin. Neurosci. 2019;64:8&#x2013;10. doi: 10.1016/j.jocn.2019.03.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2019.03.063</ArticleId><ArticleId IdType="pubmed">30955949</ArticleId></ArticleIdList></Reference><Reference><Citation>Shmara A., Perez-Rosendahl M., Murphy K., Kwon A., Smith C., Kimonis V. A clinicopathologic study of malignancy in VCP-associated multisystem proteinopathy. Orphanet J. Rare Dis. 2022;17:272. doi: 10.1186/s13023-022-02403-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-022-02403-9</ArticleId><ArticleId IdType="pmc">PMC9287862</ArticleId><ArticleId IdType="pubmed">35841038</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang W.K., Xia D. Structural and functional deviations in disease-associated p97 mutants. J. Struct. Biol. 2012;179:83&#x2013;92. doi: 10.1016/j.jsb.2012.04.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2012.04.024</ArticleId><ArticleId IdType="pmc">PMC4788498</ArticleId><ArticleId IdType="pubmed">22579784</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayraktar O., Oral O., Kocaturk N.M., Akkoc Y., Eberhart K., Kosar A., Gozuacik D. IBMPFD Disease-Causing Mutant VCP/p97 Proteins Are Targets of Autophagic-Lysosomal Degradation. PLoS ONE. 2016;11:e0164864. doi: 10.1371/journal.pone.0164864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0164864</ArticleId><ArticleId IdType="pmc">PMC5074563</ArticleId><ArticleId IdType="pubmed">27768726</ArticleId></ArticleIdList></Reference><Reference><Citation>Bersano A., Del Bo R., Lamperti C., Ghezzi S., Fagiolari G., Fortunato F., Ballabio E., Moggio M., Candelise L., Galimberti D., et al. Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation. Neurobiol. Aging. 2009;30:752&#x2013;758. doi: 10.1016/j.neurobiolaging.2007.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2007.08.009</ArticleId><ArticleId IdType="pubmed">17889967</ArticleId></ArticleIdList></Reference><Reference><Citation>Spina S., Van Laar A.D., Murrell J.R., Hamilton R.L., Kofler J.K., Epperson F., Farlow M.R., Lopez O.L., Quinlan J., DeKosky S.T., et al. Phenotypic variability in three families with valosin-containing protein mutation. Eur. J. Neurol. 2013;20:251&#x2013;258. doi: 10.1111/j.1468-1331.2012.03831.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2012.03831.x</ArticleId><ArticleId IdType="pmc">PMC3734548</ArticleId><ArticleId IdType="pubmed">22900631</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-P&#xe9;rez P., Cirulli E.T., Drory V.E., Dabby R., Nisipeanu P., Carasso R.L., Sadeh M., Fox A., Festoff B.W., Sapp P.C., et al. Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis. Neurology. 2012;79:2201&#x2013;2208. doi: 10.1212/WNL.0b013e318275963b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318275963b</ArticleId><ArticleId IdType="pmc">PMC3570818</ArticleId><ArticleId IdType="pubmed">23152587</ArticleId></ArticleIdList></Reference><Reference><Citation>Shmara A., Gibbs L., Mahoney R.P., Hurth K., Goodwill V.S., Cuber A., Im R., Pizzo D.P., Brown J., Laukaitis C., et al. Prevalence of Frontotemporal Dementia in Females of 5 Hispanic Families With R159H VCP Multisystem Proteinopathy. Neurol. Genet. 2023;9:e200037. doi: 10.1212/NXG.0000000000200037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000200037</ArticleId><ArticleId IdType="pmc">PMC9833818</ArticleId><ArticleId IdType="pubmed">36644447</ArticleId></ArticleIdList></Reference><Reference><Citation>Manno A., Noguchi M., Fukushi J., Motohashi Y., Kakizuka A. Enhanced ATPase activities as a primary defect of mutant valosin-containing proteins that cause inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia. Genes Cells. 2010;15:911&#x2013;922. doi: 10.1111/j.1365-2443.2010.01428.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2443.2010.01428.x</ArticleId><ArticleId IdType="pubmed">20604808</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta S.G., Watts G.D., Adamson J.L., Hutton M., Umberger G., Xiong S., Ramdeen S., Lovell M.A., Kimonis V.E., Smith C.D. APOE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia (IBMPFD) Genet. Med. 2007;9:9&#x2013;13. doi: 10.1097/GIM.0b013e31802d830d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/GIM.0b013e31802d830d</ArticleId><ArticleId IdType="pubmed">17224685</ArticleId></ArticleIdList></Reference><Reference><Citation>Stojkovic T., Hammouda E.H., Richard P., de Munain A.L., Ruiz-Martinez J., Gonzalez P.C., Lafor&#xea;t P., P&#xe9;nisson-Besnier I., Ferrer X., Lacour A., et al. Clinical outcome in 19 French and Spanish patients with valosin-containing protein myopathy associated with Paget&#x2019;s disease of bone and frontotemporal dementia. Neuromuscul. Disord. 2009;19:316&#x2013;323. doi: 10.1016/j.nmd.2009.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2009.02.012</ArticleId><ArticleId IdType="pubmed">19364651</ArticleId></ArticleIdList></Reference><Reference><Citation>Haubenberger D., Bittner R.E., Rauch-Shorny S., Zimprich F., Mannhalter C., Wagner L., Mineva I., Vass K., Auff E. Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP gene. Neurology. 2005;65:1304&#x2013;1305. doi: 10.1212/01.wnl.0000180407.15369.92.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000180407.15369.92</ArticleId><ArticleId IdType="pubmed">16247064</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Song C., Li C.C.H. Hexamerization of p97-VCP is promoted by ATP binding to the D1 domain and required for ATPase and biological activities. Biochem. Biophys. Res. Commun. 2003;300:253&#x2013;260. doi: 10.1016/S0006-291X(02)02840-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-291X(02)02840-1</ArticleId><ArticleId IdType="pubmed">12504076</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T.H., Pottier C., Hondius D.C., Meeter L.H., van Rooij J.G., Melhem S., van Minkelen R., van Duijn C.M., Rozemuller A.J., Seelaar H., et al. Three VCP Mutations in Patients with Frontotemporal Dementia. J. Alzheimers Dis. 2018;65:1139&#x2013;1146. doi: 10.3233/JAD-180301.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180301</ArticleId><ArticleId IdType="pubmed">30103325</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X., Qiu H. Valosin-Containing Protein, a Calcium-Associated ATPase Protein, in Endoplasmic Reticulum and Mitochondrial Function and Its Implications for Diseases. Int. J. Mol. Sci. 2020;21:3842. doi: 10.3390/ijms21113842.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21113842</ArticleId><ArticleId IdType="pmc">PMC7312078</ArticleId><ArticleId IdType="pubmed">32481679</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts G., Thomasova D., Ramdeen S., Fulchiero E., Mehta S., Drachman D., Weihl C., Jamrozik Z., Kwiecinski H., Kaminska A., et al. Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia. Clin. Genet. 2007;72:420&#x2013;426. doi: 10.1111/j.1399-0004.2007.00887.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0004.2007.00887.x</ArticleId><ArticleId IdType="pubmed">17935506</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruno F., Conidi M.E., Puccio G., Frangipane F., Lagan&#xe0; V., Bernardi L., Smirne N., Mirabelli M., Colao R., Curcio S., et al. A Novel Mutation (D395A) in Valosin-Containing Protein Gene Is Associated With Early Onset Frontotemporal Dementia in an Italian Family. Front. Genet. 2021;12:2384. doi: 10.3389/fgene.2021.795029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2021.795029</ArticleId><ArticleId IdType="pmc">PMC8669739</ArticleId><ArticleId IdType="pubmed">34917136</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards S., Aziz N., Bale S., Bick D., Das S., Gastier-Foster J., Grody W.W., Hegde M., Lyon E., Spector E., et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 2015;17:405&#x2013;424. doi: 10.1038/gim.2015.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2015.30</ArticleId><ArticleId IdType="pmc">PMC4544753</ArticleId><ArticleId IdType="pubmed">25741868</ArticleId></ArticleIdList></Reference><Reference><Citation>Ralston S.H. A New Gene for Susceptibility to Paget&#x2019;s Disease of Bone and for Multisystem Proteinopathy. J. Bone Miner. Res. 2020;35:1385&#x2013;1386. doi: 10.1002/jbmr.4090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.4090</ArticleId><ArticleId IdType="pubmed">32589291</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>